Mevacor (lovastatin) tablets

Company
Merck

Approval Status
Approved March 1999

Treatment for
Cardiology

Areas
Cardiovascular / Cardiology

Mevacor has been approved for the primary prevention of coronary heart disease in patients without symptomatic cardiovascular disease who have average to moderately elevated total-C and LDL-C and below average HDL-C.

Mevacor (lovastatin) tablets Drug Information

The Mevacor (lovastatin) tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top